Lincoln National Corp Novo Nordisk A S Transaction History

Lincoln National Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$102.11 - $135.92 $244,451 - $325,392	2,394 Added 10.09%	26,128 $3.35 Million
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $480,858 - $577,655	5,478 Added 30.01%	23,734 $2.46 Million
Q3 2023 Nov 03, 2023	BUY	$90.94 - $199.54 $873,114 - $1.92 Million	9,601 Added 110.93%	18,256 $1.66 Million
Q2 2023 Aug 04, 2023	BUY	$155.98 - $172.65 $101,075 - $111,877	648 Added 8.09%	8,655 $1.4 Million
Q1 2023 May 01, 2023	BUY	$132.34 - $159.14 $45,260 - $54,425	342 Added 4.46%	8,007 $1.27 Million
Q4 2022 Feb 07, 2023	BUY	$102.55 - $135.33 $106,036 - $139,931	1,034 Added 15.59%	7,665 $1.04 Million
Q3 2022 Nov 03, 2022	BUY	$95.28 - $116.93 $51,165 - $62,791	537 Added 8.81%	6,631 $661,000
Q2 2022 Aug 02, 2022	BUY	$103.24 - $121.81 $94,980 - $112,065	920 Added 17.78%	6,094 $679,000
Q1 2022 May 09, 2022	BUY	$93.1 - $112.54 $17,689 - $21,382	190 Added 3.81%	5,174 $574,000
Q4 2021 Jan 26, 2022	BUY	$95.88 - $117.08 $270,956 - $330,868	2,826 Added 130.95%	4,984 $558,000
Q3 2021 Nov 05, 2021	SELL	$84.42 - $106.62 $24,903 - $31,452	-295 Reduced 12.03%	2,158 $207,000
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $203,656 - $255,127	-3,010 Reduced 55.1%	2,453 $205,000
Q1 2021 May 10, 2021	BUY	$67.06 - $75.82 $366,348 - $414,204	5,463 New	5,463 $369,000
Q1 2018 May 09, 2018	SELL	$48.49 - $58.14 $203,706 - $244,246	-4,201 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$47.53 - $53.73 $199,673 - $225,719	4,201	4,201 $225,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $252B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.